The present invention provides a fused heterocyclic derivative having a strong kinase inhibitory activity and use thereof.
The present invention relates to a compound represented by the formula
wherein each symbol is as defined in the present specification, or a salt thereof.
The present invention provides a fused heterocyclic derivative having a strong kinase inhibitory activity and use thereof.
The present invention relates to a compound represented by the formula
wherein each symbol is as defined in the present specification, or a salt thereof.
Split-split. A multiple synthesiser approach to efficient automated parallel synthesis
作者:Paul Brooking、Andrew Doran、Paul Grimsey、Nicholas W. Hird、William S. MacLachlan、Mythily Vimal
DOI:10.1016/s0040-4039(98)02620-3
日期:1999.2
A multiple synthesiser approach to high efficiency, high throughput synthesis is described. It involves eliminating duplication in multi-step synthesis by establishing a cascade of matched synthesisers in which each machine performs a single step and provides feedstocks for the next instrument. The utility of this approach is illustrated by the efficient construction of a large array by a 4 step solution synthesis. (C) 1999 Elsevier Science Ltd. All rights reserved.
PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES
申请人:Array BioPharma Inc.
公开号:EP3843850A1
公开(公告)日:2021-07-07
PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS AS INHIBITORS OF TAM AND MET KINASES
申请人:Array BioPharma Inc.
公开号:US20200079770A1
公开(公告)日:2020-03-12
Provided herein are compounds of the Formula I:
and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, wherein R
1
, R
2
, R
9
, X
1
and G are as defined herein, which are inhibitors of one or more TAM kinases and/or c-Met kinase, and are useful in the treatment and prevention of diseases which can be treated with a TAM kinase inhibitor and/or a c-Met kinase inhibitor.